Wegovy, Zepbound makers' stocks rally as a weight-loss-drug competitor drops out

  • Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift in early Monday trading, after a potential competitor decided to cancel development of its GLP-1 drug.